43 related articles for article (PubMed ID: 38486347)
1. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
Muro Y; Ishikawa A; Sugiura K; Akiyama M
Rheumatology (Oxford); 2012 Aug; 51(8):1508-13. PubMed ID: 22539482
[TBL] [Abstract][Full Text] [Related]
3. The association between Mi-2 antibodies and dermatomyositis.
Targoff IN; Reichlin M
Arthritis Rheum; 1985 Jul; 28(7):796-803. PubMed ID: 2409985
[TBL] [Abstract][Full Text] [Related]
4. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis.
Cruellas MG; Viana Vdos S; Levy-Neto M; Souza FH; Shinjo SK
Clinics (Sao Paulo); 2013 Jul; 68(7):909-14. PubMed ID: 23917652
[TBL] [Abstract][Full Text] [Related]
5. Anti-Mi-2 antibody-positive dermatomyositis following Spirulina intake.
Kuzumi A; Yoshizaki A; Kawanabe R; Sato S
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38486347
[No Abstract] [Full Text] [Related]
6. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
He L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
[TBL] [Abstract][Full Text] [Related]
7. Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy.
Akiyama C; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Jul; 42(7):1271-1280. PubMed ID: 33837447
[TBL] [Abstract][Full Text] [Related]
8. Rare myositis-specific autoantibody associations among Hungarian patients with idiopathic inflammatory myopathy.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Jobanputra R; Dankó K
Acta Reumatol Port; 2015; 40(4):337-47. PubMed ID: 26922197
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic inflammatory myopathy: autoantibody update.
Targoff IN
Curr Rheumatol Rep; 2002 Oct; 4(5):434-41. PubMed ID: 12217249
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of dermatomyositis characterized by myositis-specific autoantibodies.
Okiyama N; Fujimoto M
F1000Res; 2019; 8():. PubMed ID: 31824645
[TBL] [Abstract][Full Text] [Related]
11. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
